Arabinogalactan for enhancing the adaptive immune response
AssigneeLonza Ltd.
InventorsBryan Rodriguez, Kevin Q. Owen, Ulla Freitas, Jay Udani
Life of this patent
Estimating the term…
Abstract
The present invention discloses a composition containing Arabinogalactan for enhancing the adaptive immune response in subjects to foreign antigen(s) by administering said composition prior, during and after the phase of exposure to said foreign antigen(s). Furthermore, the present invention relates to a vaccination kit comprising a composition comprising Arabinogalactan and a vaccine.
Claims5
A kit comprising a composition consisting essentially of:
- 1) the polysaccharide Arabinogalactan and/or at least one Arabinogalactan derivative, and 2) a vaccine, wherein said Arabinogalactan derivative is selected from the group consisting of Arabinogalactan proteins and quaternized forms of Arabinogalactan.
A method for enhancing the adaptive immune response against foreign antigen(s), the method comprising administration of a composition consisting essentially of:
- 1) the polysaccharide Arabinogalactan and/or at least one Arabinogalactan derivative, and 2) a vaccine, wherein said Arabinogalactan derivative is selected from the group consisting of Arabinogalactan proteins and quaternized forms of Arabinogalactan.
Dependencies are inferred from the claim text.